In brief
The Trump administration has revealed plans to cut up to $4 billion in overhead costs linked to biomedical research grants. The National Institutes of Health (NIH) announced that it will reduce the funding for "indirect costs"—which cover expenses such as facilities, utilities, and essential equipment. In a bid to maximize direct research funding, the NIH will cap indirect research costs at 15 percent, significantly lower than the current average of 30 percent. These changes are set to take effect immediately. Elon Musk, head of the newly established Department of Government Efficiency, stressed that some universities have mismanaged funds, claiming they had used as much as 60 percent of research grants for overhead expenses.
However, the reduction has alarmed many in the scientific community. The Association of American Medical Colleges warned that these new measures could severely compromise the nation's research capabilities, potentially slowing progress in medical science and obstructing the development of new treatments and technologies. Stanford's Anusha Kalbasi emphasized the need for such grants to maintain laboratory safety and operational efficiency, predicting devastating outcomes even for well-funded institutions. Other educational leaders echoed similar sentiments, noting that these reductions could impede the maintenance of advanced laboratories and infrastructure critical for global competitiveness. With opposition mounting, including potential lawsuits, critics stress that these cuts could jeopardize the future of medical research and public health. The suggestion for these caps originated from Project 2025, a conservative proposal by the Heritage Foundation aimed at reducing government expenditures in academic research.
